IPOs this week : Feb 14 - 18, 2022 (wk 7)

No IPOs are expected to start trading next week. 

IPO quiet period expirations

• NSTS Bancorp(NASDAQ:NSTS) on February 14. 

IPO lockup expirations

• Crescent Capital (NASDAQ:CCAP) on February 14, 
• Iris Energy (NASDAQ:IREN) on February 15, 
• Newlake Capital Partners (OTCQX:NLCP), Sweetgreen (NYSE:SG) and UserTesting (NYSE:USER) on February 16 and 
• CYNGN (NASDAQ:CYN) on February 17. 

The IPO lockups cover only certain blocks of shares. 

On the SPAC calendar, shareholder votes are set for the Roth CH Acquisition III Co. (NASDAQ:ROCR) deal to take QualTek public, the Astrea Acquisition Corp (NASDAQ:ASAX) deal to take both HotelPlanner and Reservations.com public, as well as the Healthcare Capital Corp. (NASDAQ:HCCC) deal to take Alpha Tau Medical public.

IPOs this week : Dec. 13 - 17, 2021 (wk 50)

IPOs expected to price

• Fresh Vine Wine (VINE), Samsara (IOT) and Sidus Space (SIDU). 

IPO quiet period expirations

• Braze (NASDAQ:BRZE), Iris Energy (NASDAQ:IREN), Sono Group (NASDAQ:SEV), Sweetgreen (NYSE:SG), Crescent Capital BDC (NASDAQ:CCAP) and UserTesting (NYSE:USER) on December 13, 
• Finwise (NASDAQ:FINW), Snow Lake Resources (NASDAQ:LITM) and Advanced Human Imaging (NASDAQ:AHI) on December 14. 

IPO lockup expirations

• WalkMe (NASDAQ:WKME), Convey Health Solutions (NYSE:CNVY), Alzamend Neuro (NASDAQ:ALZN), ATRenew (NYSE:RERE), Century Therapeutics (NASDAQ:IPSC), Atai Life Sciences (NASDAQ:ATAI), Cyteir Therapeutics (NASDAQ:CYT), Ambrx Biopharma (NYSE:AMAM), Codex DNA (NASDAQ:DNAY), Femasys (NASDAQ:FEMY) and Meiwu Technology (NASDAQ:WNW)